A61P 19/00
Drugs for skeletal disorders
A61P19/00 (Drugs for skeletal disorders) appears on 32,451 US grants and 50,390 published applications in this corpus.
Search patents in A61P- Granted patents
- 32,451
- Published applications
- 50,390
- Assignees
- 10,469
- Inventors
- 64,839
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 5 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 6 | 0 |
| 1987 | 10 | 0 |
| 1988 | 4 | 0 |
| 1989 | 11 | 0 |
| 1990 | 10 | 0 |
| 1991 | 20 | 0 |
| 1992 | 16 | 0 |
| 1993 | 28 | 0 |
| 1994 | 47 | 0 |
| 1995 | 71 | 0 |
| 1996 | 93 | 0 |
| 1997 | 155 | 0 |
| 1998 | 233 | 0 |
| 1999 | 357 | 0 |
| 2000 | 375 | 0 |
| 2001 | 563 | 171 |
| 2002 | 702 | 1018 |
| 2003 | 735 | 1712 |
| 2004 | 614 | 2161 |
| 2005 | 660 | 2227 |
| 2006 | 904 | 2219 |
| 2007 | 994 | 2319 |
| 2008 | 1036 | 2766 |
| 2009 | 1251 | 3151 |
| 2010 | 1738 | 3603 |
| 2011 | 1812 | 3380 |
| 2012 | 2094 | 3145 |
| 2013 | 2406 | 2490 |
| 2014 | 2269 | 2576 |
| 2015 | 1966 | 2267 |
| 2016 | 1663 | 2202 |
| 2017 | 1697 | 2023 |
| 2018 | 1428 | 1807 |
| 2019 | 1416 | 1760 |
| 2020 | 1228 | 1528 |
| 2021 | 988 | 1323 |
| 2022 | 752 | 1172 |
| 2023 | 620 | 1013 |
| 2024 | 559 | 962 |
| 2025 | 576 | 854 |
| 2026 | 316 | 541 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Use of porous calcium-based granules for promoting healing of an intra-articular or peri-articular fracture of a fractured bone6 Oct 2026US 12,751,970 B2Joy Medical Devices Corporation
- Polymeric patch scaffolds for articular cartilage regeneration6 Oct 2026US 12,752,041 B2University of Southern California
- Protein with anti-inflammatory properties6 Oct 2026US 12,753,214 B2Revolo Biotherapeutics Limited
- Aggrecan binding immunoglobulins6 Oct 2026US 12,753,224 B2Ablynx N. V.
- Methods for treating bone-related disorders22 Sep 2026US 12,740,963 B2University of Maryland, Baltimore
- Methods of preventing post-traumatic osteoarthritis using metformin8 Oct 2026US 2026/0306428 A1
- Very long chain fatty acids for use in mineralization8 Oct 2026US 2026/0306434 A1Epax Norway AS
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Methods of treating rheumatoid arthritis, chronic spontaneous urticaria, and systemic lupus erythematosis using an inhibitor of bruton's tyrosine kinase8 Oct 2026US 2026/0306487 A1Genentech, Inc.
- Composition comprising homogeneous polysaccharide or derivative thereof and method of using the same to prevent and/or treat bone loss8 Oct 2026US 2026/0306529 A1
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Cartilage repair apparatus and method1,489US 7,361,195 B2DePuy Products, Inc. · 2008
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001